Akari Therapeutics (AKTX) Shares Outstanding (2011 - 2026)

Akari Therapeutics' Shares Outstanding history runs 16 years deep, the most recent figure standing at $80000.0 for Q1 2026.

• In Q1 2026, Shares Outstanding fell 100.0% year-over-year to $80000.0; the TTM figure through Mar 2026 stood at $80000.0 (down 100.0% YoY), while the FY2025 annual figure was $90.5 billion, up 70.22% from the prior year.
• Shares Outstanding came in at $80000.0 for Q1 2026 at Akari Therapeutics, down from $90.5 billion in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $91.6 billion in Q1 2026 to a low of $7.4 billion in Q4 2022.
• A 5-year average of $38.5 billion and a median of $24.3 billion in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding jumped 301.89% in 2024 and slumped 100.0% in 2026, its largest moves.
• Akari Therapeutics' Shares Outstanding stood at $7.4 billion in 2022, then soared by 77.76% to $13.2 billion in 2023, then surged by 301.89% to $53.2 billion in 2024, then soared by 70.22% to $90.5 billion in 2025, then slumped by 100.0% to $80000.0 in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $80000.0, $90.5 billion, and $65.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison